VersaPharm - Ownership and Business Overview

Life ScienceCompany

VersaPharm Ownership

Who owns VersaPharm?

VersaPharm is owned by Akorn. It was acquired on August 12, 2014.

Was VersaPharm formerly PE-backed?

Yes. VersaPharm was formerly owned by 1 private investor.

VersaPharm Business Overview

Where is VersaPharm headquartered?

VersaPharm is headquartered in Marietta, Georgia.

What sector is VersaPharm in?

VersaPharm is a life science company.

When was VersaPharm founded?

VersaPharm was founded in 1994.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 236 acquisitions of life science companies in 2014, including 21 acquisitions by private equity firms, and 215 by strategics.

VersaPharm, Inc.

1775 West Oak Parkway, Suite 800,
Marietta, Georgia 30062-2260
United States,
(800) 548-0700
www.versapharm.com

VersaPharm is a generic pharmaceuticals company serving niche markets. VersaPharm has commercialized and developed generic products aimed at treating tuberculosis and other infectious diseases, bleeding disorders, and diseases of the central nervous system.


 Subscribe to unlock this and 202,489
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.